123 related articles for article (PubMed ID: 3510682)
21. Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96.
Tennvall J; Garkavij M; Chen J; Sjögren HO; Strand SE
Cancer; 1997 Dec; 80(12 Suppl):2411-8. PubMed ID: 9406691
[TBL] [Abstract][Full Text] [Related]
22. Avidin-biotin immunoadsorption for ex vivo bone marrow purging: effect of percentage of target cells and flow rate.
Lemoli RM; Gobbi M; Tazzari PL; Grassi G; Dinota A; Gherlinzoni F; Mazza P; Tura S
Haematologica; 1988; 73(3):183-5. PubMed ID: 3139512
[No Abstract] [Full Text] [Related]
23. High efficiency of a new immunological magnetic cell sorting method for T cell depletion of human bone marrow.
Kögler G; Capdeville AB; Hauch M; Brüster HT; Göbel U; Wernet P; Burdach S
Bone Marrow Transplant; 1990 Sep; 6(3):163-8. PubMed ID: 2252955
[TBL] [Abstract][Full Text] [Related]
24. Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow.
Muirhead M; Martin PJ; Torok-Storb B; Uhr JW; Vitetta ES
Blood; 1983 Aug; 62(2):327-32. PubMed ID: 6409188
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96.
Chen JQ; Strand SE; Tennvall J; Lindgren L; Hindorf C; Sjögren HO
J Nucl Med; 1997 Dec; 38(12):1934-9. PubMed ID: 9430473
[TBL] [Abstract][Full Text] [Related]
26. Biotinylation of interleukin-2 (IL-2) for flow cytometric analysis of IL-2 receptor expression. Comparison of different methods.
De Jong MO; Rozemuller H; Bauman JG; Visser JW
J Immunol Methods; 1995 Jul; 184(1):101-12. PubMed ID: 7622862
[TBL] [Abstract][Full Text] [Related]
27. A simple method for immunoselective cell separation with the avidin-biotin system.
Wormmeester J; Stiekema F; De Groot K
J Immunol Methods; 1984 Mar; 67(2):389-94. PubMed ID: 6368688
[TBL] [Abstract][Full Text] [Related]
28. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
Hoya K; Guterman LR; Miskolczi L; Hopkins LN
Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
[TBL] [Abstract][Full Text] [Related]
29. Improved enzyme immunoassays using biotin-avidin-enzyme complex.
Shamsuddin AM; Harris CC
Arch Pathol Lab Med; 1983 Oct; 107(10):514-7. PubMed ID: 6351799
[TBL] [Abstract][Full Text] [Related]
30. Separation of spleen colony-forming units and prothymocytes by use of a monoclonal antibody detecting an H-2K determinant.
Mulder AH; Bauman JG; Visser JW; Boersma WJ; van den Engh GJ
Cell Immunol; 1984 Oct; 88(2):401-10. PubMed ID: 6207943
[TBL] [Abstract][Full Text] [Related]
31. Affinity cleavage of cell surface antibodies using the avidin-biotin system.
Alon R; Bayer EA; Wilchek M
J Immunol Methods; 1993 Sep; 165(1):127-34. PubMed ID: 8409464
[TBL] [Abstract][Full Text] [Related]
32. Isolation of murine pluripotent hemopoietic stem cells.
Visser JW; Bauman JG; Mulder AH; Eliason JF; de Leeuw AM
J Exp Med; 1984 Jun; 159(6):1576-90. PubMed ID: 6427383
[TBL] [Abstract][Full Text] [Related]
33. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
[TBL] [Abstract][Full Text] [Related]
34. Transplantation of CD34+ hematopoietic progenitor cells.
Berenson RJ; Shpall EJ; Auditore-Hargreaves K; Heimfeld S; Jacobs C; Krieger MS
Cancer Invest; 1996; 14(6):589-96. PubMed ID: 8951362
[TBL] [Abstract][Full Text] [Related]
35. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
36. Magnetic affinity colloid (MAC) cell separation of leukemia cells from autologous bone marrow aspirates.
Reading CL; Thomas MW; Hickey CM; Chandran M; Tindle S; Ball ED; Poynton CH; Dicke KA
Leuk Res; 1987; 11(12):1067-77. PubMed ID: 3695563
[TBL] [Abstract][Full Text] [Related]
37. Quantitative flow cytometric and clonogenic evaluation of glass bead affinity fractionation of antibody-labeled murine bone marrow.
Matsson P; Pallavicini MG; Summers L
J Immunol Methods; 1987 Dec; 105(1):45-53. PubMed ID: 3316406
[TBL] [Abstract][Full Text] [Related]
38. Assessment of methylprednisolone purging efficacy on Daudi burkitt lymphoma cells from normal bone marrow.
Janakiraman N; Niewenhuis LM
Henry Ford Hosp Med J; 1991; 39(2):117-22. PubMed ID: 1890005
[TBL] [Abstract][Full Text] [Related]
39. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A
Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468
[TBL] [Abstract][Full Text] [Related]
40. Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement.
De Fabritiis P; Bregni M; Lipton J; Greenberger J; Nadler L; Rothstein L; Korbling M; Ritz J; Bast RC
Blood; 1985 May; 65(5):1064-70. PubMed ID: 3995166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
